These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4083843)

  • 1. [Bladder tumors in subjects younger than 40 years of age].
    Le Guillou M; Ferrière JM; Barthaburu D; Nony P; Piechaud T
    Ann Urol (Paris); 1985; 19(5):345-8. PubMed ID: 4083843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bladder tumors in patients under 40 years of age].
    Njeh M; Kechaou M; Jeribi M; Mhiri MN
    Ann Urol (Paris); 1994; 28(5):268-9. PubMed ID: 7825985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. A study of 567 cases of urinary-tract disorder including 170 untreated and 182 irradiated bladder tumors.
    Esposti PL; Moberger G; Zajicek J
    Acta Cytol; 1970 Mar; 14(3):145-55. PubMed ID: 4985639
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
    Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
    Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder.
    Ianari A; Sternberg CN; Rossetti A; Van Rijn A; Deidda A; Giannarelli D; Pansadoro V
    Urology; 1997 May; 49(5):786-9. PubMed ID: 9145993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Your patient with carcinoma of the urinary bladder. Options for organ preservation].
    Zaak D
    MMW Fortschr Med; 2003 Jan; 145(5):28-32. PubMed ID: 12619205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FISH test for the diagnosis, surveillance, and prognosis of transitional cell carcinoma of the bladder.
    Haddad FS
    J Med Liban; 2008; 56(4):230-2. PubMed ID: 19115598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoscopic surgery of superficial bladder tumors: a homogeneous series of 146 cases].
    Virseda JA; Gómez A; Bolaño N; Melchor A
    Actas Urol Esp; 1985; 9(6):501-6. PubMed ID: 3832829
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
    J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy and follow-up of superficial bladder cancer in in patients less than 30 years of age].
    Erpenbach K; Roth S; Rathert P
    Urologe A; 1994 Nov; 33(6):475-8. PubMed ID: 7817442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.